Adriana M. Strutt

TL;DR: The ALS-CBS™ can aid in detecting cognitive and behavioral impairment in a clinical setting, although it does not replace formal diagnostic assessment and further validation with larger sample sizes will clarify its clinical utility.

TL;DR: A change in BMI after ALS diagnosis was significantly associated with rate of progression and survival, raising the possibility that early changes in BMI may identify patients likely to have a more malignant course of the disease.

TL;DR: This work aimed to determine the prevalence of frontal‐lobe mediated behavioral impairment in Amyotrophic Lateral Sclerosis and to ascertain its relationship to cognitive impairment.

TL;DR: There is a need for assessments that reflect real‐world situations so as to better assess functional disability and it is especially important to develop assessment tools that are useful in ethnically, culturally, and linguistically diverse populations as well as in individuals with neurodegenerative disease other than AD.

TL;DR: The hypothesis that diabetes mellitus type 2 would have a positive effect on the motor and cognitive findings of ALS was tested.